Search details
1.
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature
; 620(7973): 409-416, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37532934
2.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Article
in English
| MEDLINE | ID: mdl-33931486
3.
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.
Clin Cancer Res
; 30(10): 2111-2120, 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38502104
4.
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.
Breast Cancer (Dove Med Press)
; 15: 311-325, 2023.
Article
in English
| MEDLINE | ID: mdl-37139242
5.
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
Neuro Oncol
; 23(11): 1949-1960, 2021 11 02.
Article
in English
| MEDLINE | ID: mdl-33825892
6.
Flow antagonizes TNF-alpha signaling in endothelial cells by inhibiting caspase-dependent PKC zeta processing.
Circ Res
; 101(1): 97-105, 2007 Jul 06.
Article
in English
| MEDLINE | ID: mdl-17525369
7.
BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha.
Circ Res
; 96(11): 1145-51, 2005 Jun 10.
Article
in English
| MEDLINE | ID: mdl-15879308
8.
Flow-mediated signaling modulates endothelial cell phenotype.
Endothelium
; 13(6): 375-84, 2006.
Article
in English
| MEDLINE | ID: mdl-17169770
9.
Tissue-resident bone marrow-derived progenitor cells: key players in hypoxia-induced angiogenesis.
Circ Res
; 97(10): 955-7, 2005 Nov 11.
Article
in English
| MEDLINE | ID: mdl-16284185
10.
Vascular shear stress and activation of inflammatory genes.
Curr Atheroscler Rep
; 8(3): 240-4, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16640961
11.
6A3-5/Osa2 is an early activated gene implicated in the control of vascular smooth muscle cell functions.
J Biomed Biotechnol
; 2006(5): 97287, 2006.
Article
in English
| MEDLINE | ID: mdl-17489020
12.
Identification, structural, and functional characterization of a new early gene (6A3-5, 7 kb): implication in the proliferation and differentiation of smooth muscle cells.
J Biomed Biotechnol
; 2005(3): 254-70, 2005.
Article
in English
| MEDLINE | ID: mdl-16192684
13.
Ischemia induces early expression of a new transcription factor (6A3-5) in kidney vascular smooth muscle cells: studies in rat and human renal pathology.
Am J Pathol
; 163(6): 2485-94, 2003 Dec.
Article
in English
| MEDLINE | ID: mdl-14633620
Results
1 -
13
de 13
1
Next >
>>